AUtoimmunity PRofile in INterferon β-1a treated multiple sclerosis patients.: The AUPRIN study:: comparison of 2 different dosage of subcutaneous interferon-β-1a

被引：0
|
作者：
Verdun, E
Ricci, A
Cucci, MA
Barbero, P
Pipieri, A
Clerico, M
Giordano, L
Delfico, L
Tassinari, T
Motti, L
Paciello, M
Reggio, A
Aimo, G
Durelli, L
机构：
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [21] The use of interferon-β-1a (Rebif®) in children and adolescents with multiple sclerosis
    Pohl, D
    Rostasy, K
    Hanefeld, E
    Gärtner, J
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S250 - S250
  • [22] Haematological effects of interferon-β-1a (Rebif®) therapy in multiple sclerosis
    Rieckmann, P
    O'Connor, P
    Francis, GS
    Wetherill, G
    Alteri, E
    DRUG SAFETY, 2004, 27 (10) : 745 - 756
  • [23] Haematological Effects of Interferon-β-1a (Rebif®) Therapy in Multiple Sclerosis
    Peter Rieckmann
    Paul O’Connor
    Gordon S. Francis
    Graham Wetherill
    Enrica Alteri
    Drug Safety, 2004, 27 : 745 - 756
  • [24] Acute and chronic neuroendocrine effects of interferon-β 1a in multiple sclerosis
    Bergh, Florian Then
    Kruempfel, Tania
    Yassouridis, Alexander
    Lechner, Christian
    Holsboer, Florian
    Trenkwalder, Claudia
    CLINICAL ENDOCRINOLOGY, 2007, 66 (02) : 295 - 303
  • [25] Safety of adult doses of subcutaneous interferon-β-1a in children and adolescents with multiple sclerosis: results of the REPLAY study
    Ghezzi, A.
    Pohl, D.
    Banwell, B.
    Krupp, L. B.
    Boyko, A.
    Meinel, M.
    Lehr, L.
    Moraga, M. Stam
    Tenembaum, S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 74 - 75
  • [26] Differential immunomodulatory effects of interferon-β1a/1b in patients with multiple sclerosis
    Papachroni, K.
    Fragoulis, N.
    Piperi, C.
    Patrikiou, A.
    Papadimitriou, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 142 - 142
  • [27] Combined treatment of multiple sclerosis patients with cytostatics and interferon-β (1a,1b)
    Daskalovska, V
    Dimova, A
    Bojkovski, V
    Boskova-Petkovska, T
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S262 - S262
  • [28] Nephrotic syndrome in a multiple sclerosis patient treated with interferon β1a
    Auty, A
    Saleh, A
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2005, 32 (03) : 366 - 368
  • [29] Changes in plasma cytokines induced by interferon-β1a treatment in patients with multiple sclerosis
    Duddy, ME
    Armstrong, MA
    Crockard, AD
    Hawkins, SA
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 101 (01) : 98 - 109
  • [30] Subcutaneous Interferon β-1a in Children and Adolescents with Multiple Sclerosis: An International Retrospective Study of 307 Patients
    Pohl, Daniela
    Banwell, Brenda
    Ghezzi, Angelo
    Krupp, Lauren
    Boyko, Alexey
    Meinel, Michel
    Rocak, Sanda
    Moraga, Margot Stam
    Tenembaum, Silvia
    NEUROLOGY, 2012, 78
12345